In humans, hookworm parasites can help prevent the development of type 2 diabetes. These conclusions were reached by scientists at James Cook University (JCU) in Australia, writes Slashdot.
The corresponding human study lasted for two years. It involved 40 participants aged 27 to 50 with early signs of metabolic disease. The researchers published the test results in the journal Nature Communications.
During the study, some patients received 20 or 40 larvae of the parasite Necator americanus. Another group was given a placebo. In the end, people with the parasites showed a decrease in insulin resistance. This indicates that people experienced an improvement in insulin sensitivity.
“All trial participants had risk factors for developing cardiovascular disease and type 2 diabetes,” said Dr Doris Pierce, from JCU’s Australian Institute of Tropical Health and Medicine (AITHM).
According to him, the trial showed significant metabolic benefits for the recipients who underwent this treatment, especially for those infected with 20 larvae.
Earlier it was reported that the United States is working on a unique gene therapy for type 2 diabetes. Fractyl Health, a US-based biotechnology company, is in the early stages of developing a one-time gene therapy to reduce blood sugar and body weight.